SCHEMBL7676249

SCHEMBL7676249

COc1nc2cc(Cl)c(Cl)c(-c3ncn(C)n3)c2nc1OC

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.36
PTGES O14684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7676533 0.75 HRH4 (0.36) HRH4
SCHEMBL7680475 0.75 HRH4 (0.36) HRH4
SCHEMBL7681496 0.74 SMN1; SMN2 (0.43) HRH4
SCHEMBL7680558 0.72 SMN1; SMN2 (0.37) HRH4PTGES
SCHEMBL7676130 0.71 MAPT (0.40) PTGES
SCHEMBL7473964 0.70 HRH4 (0.39) HRH4PTGES
SCHEMBL7824628 0.70 P2RX7 (0.33) HRH4
SCHEMBL16586567 0.70 PDPK1 (0.34)
SCHEMBL6680601 0.69 HRH4 (0.38) HRH4PTGES
SCHEMBL7676206 0.69 HRH4 (0.38) HRH4PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed